CENP-V As a Potential Diagnostic Marker of Damage in Human Oocytes

Clinical trial NCT06788379 · RECRUITING

Trial details

NCT number: NCT06788379
Sponsor: Vida Recoletas Sevilla
Status: RECRUITING
Study type: OBSERVATIONAL

Establish the Amount of CENPV Protein in Human Oocytes As a Diagnostic Tool Against Damage Caused by Ageing or by the Procedure of Vitrification of Oocytes Advance Maternal Age Vitrification and Thawing

Start date: 2024-10-04
Primary completion: 2026-06-30
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.